Navigation Links
SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
Date:4/23/2009

San Diego, April 23 /PRNewswire-FirstCall/ -- SEQUENOM, Inc. (Nasdaq: SQNM), today announced that it will report first quarter 2009 financial results after market close on Thursday, April 30, 2009. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.

    Conference Call Information:
    Domestic callers: 1 (866) 844-2998
    International callers: 1 (706) 679-9912

Webcast information: Visit the investor relations section at www.sequenom.com.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).

A webcast replay will be available on the SEQUENOM Web site for 14 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing (800) 642-1687 for domestic callers, or (706) 645-9291 for international callers, and entering reservation code 93862699.

About SEQUENOM

SEQUENOM is committed to providing the best genetic analysis products that translate the results of genomic science into solutions for noninvasive prenatal diagnostics, biomedical research, translational research and molecular medicine applications. The company's proprietary MassARRAY(R) system is a high-performance (in speed, accuracy and cost efficiency) nucleic acid analysis platform that quantitatively and precisely measures genetic target material and variations. The company has exclusively licensed intellectual property rights for the development and commercialization of noninvasive prenatal genetic tests for use with the MassARRAY system and other platforms. SEQUENOM maintains a website at www.sequenom.com to which SEQUENOM regularly posts copies of its press releases as well as additional information about SEQUENOM. Interested persons can subscribe on the SEQUENOM website to email alerts or RSS feeds that are sent automatically when SEQUENOM issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

SEQUENOM(R) and MassARRAY(R) are trademarks of SEQUENOM, Inc.

    Company Contact
    Ian Clements
    Sr. Director, Corp. Communications
    +1 (858) 202-9000

    Investor Relations Contact
    Lippert/Heilshorn & Associates
    Jody Cain (jcain@lhai.com)
    Kevin Mc Cabe (kmccabe@lhai.com)
    +1 (310) 691-7100

    Media Relations
    Pure Communications
    Sheryl Seapy
    +1 (949) 608-0841


'/>"/>
SOURCE SEQUENOM, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
2. Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
3. Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
4. SENOMYX, INC. FIRST QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR MAY 7, 2009
5. Insmed to Host First Quarter 2009 Conference Call
6. Essilor : 2009 First Quarter Report
7. Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2009 Financial Results
8. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
9. ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
10. SiliconSky GPS Designs First AGPS-Enabled Asthma Inhaler for Landmark Research Program
11. Z Therapy Is The First In North Texas To Offer Revolutionary Treatment Option For Neck Pain Sufferers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... ... pasteurized cold-pressed fruit and vegetable drink brand is now available on ... USA, LLC to manufacture and distribute the Vegesentials line of juices throughout ...
(Date:2/27/2017)... , Feb. 27, 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ... their expiry on Friday, February 24, 2017 a total of ... price of $0.13 per common share. Proceeds from the exercise ... issued from InMed,s Treasury.   ... "We are grateful for this expression of ...
(Date:2/27/2017)... , February 27, 2017 Four ... for evaluation today, and they are: Anthera Pharmaceuticals Inc. ... of California Inc. (NASDAQ: PACB), and Conatus Pharmaceuticals Inc. ... on ETF Trends, market observers are growing more bullish ... could enact reforms to free cash held overseas for ...
(Date:2/27/2017)... , Feb. 27, 2017 Fluxion Biosciences ... Spain has been appointed as a Certified ... The IsoFlux system will be used in Genetracer Biotech,s ... to lung and colon cancer, with plans to move ... laboratory is utilizing Fluxion,s IsoFlux System to isolate, recover, ...
Breaking Biology Technology:
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
(Date:2/2/2017)... NEW YORK , Feb. 2, 2017  EyeLock ... has released a new white paper " What You ... The problem of ensuring user authenticity is a ... protect the authentication of users. However, traditional authentication schemes ... Biometric authentication offers an elegant ...
(Date:1/26/2017)... Jan. 26, 2017  Crossmatch, a leading provider of ... solution aimed at combatting fraud, waste and abuse in ... at the Action on Disaster Relief conference in ... for UN agencies and foreign assistance organizations throughout ... and abuse are a largely unacknowledged problem in the ...
Breaking Biology News(10 mins):